Agilent buys Her2 test firm

Saved in:
Bibliographic Details
Published in:Nature biotechnology 2012-08, Vol.30 (8), p.730-730
Main Author: Aldridge, Susan
Format: Article
Language:English
Subjects:
631/61
706/703/66
Agriculture
Antibodies
Antineoplastic agents
Bioinformatics
Biomedical Engineering/Biotechnology
Biomedical laboratories
Biomedicine
Biotechnology
Breast cancer
Cancer therapies
Diabetes
Drug approval
FDA approval
Instrument industry
Instrument industry (Equipment)
Life Sciences
Medical laboratories
Medical tests
Mergers, acquisitions and divestments
news
Peptides
Pertuzumab
Response rates
Technology
Toxicity
Vendor relations
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1087-0156
1546-1696
DOI:10.1038/nbt0812-730b